6628 — Transcenta Holding Share Price
0.000.00%
Last trade - 00:00- HK$807.29m
- HK$659.97m
- CNY53.85m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.73 | ||
| Price to Tang. Book | 1.63 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 13.88 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -39.23% | ||
| Return on Equity | -36.98% | ||
| Operating Margin | -829.81% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 44.14 | 80.98 | 50.24 | 101.89 | 53.85 | 161.36 | 168.46 | 5.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Transcenta Holding Limited is a China-based investment holding company engaged in the discovery, research, development, manufacturing and business development of biopharmaceuticals in the clinical stage. The Company's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The Company's all products are in the research and development (R&D) stage and have not been commercialized. The Company also provides contract developmentand manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.
Directors
- Yining Zhao NEC (49)
- Xueming Qian CEO (53)
- Weng Xiaolu CFO
- Feng Ye COO (53)
- Christopher Hwang EVP (57)
- Xiaoming Yang EVP (58)
- Ming Shi EVP (55)
- Da Zhu SVF (40)
- Yi Gu SVP (52)
- Jane Qin Xia VPR (52)
- Kwan Wai Leung SEC
- Jun Bao NID (54)
- Jiasong Tang NID (47)
- Zhihua Zhang NID (39)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 20th, 2010
- Public Since
- September 29th, 2021
- No. of Employees
- 215
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 436,375,375
- Address
- B6-501, Biobay, 218 Xinghu Street, SUZHOU, 215123
- Web
- https://www.transcenta.com/
- Phone
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 6628
Transcenta Holding Limited Annual Shareholders Meeting
Similar to 6628
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Transcenta Holding share price?
As of Today at 18:28 UTC, shares in Transcenta Holding are trading at HK$1.85. This share price information is delayed by 15 minutes.
How has the Transcenta Holding share price performed this year?
Shares in Transcenta Holding last closed at HK$1.85 and the price had moved by -63% over the past 365 days. In terms of relative price strength the Transcenta Holding share price has underperformed the FTSE Developed Asia Pacific Index by -64.71% over the past year.
What are the analyst and broker recommendations for Transcenta Holding?
The overall consensus recommendation for Transcenta Holding is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Transcenta Holding dividend yield?
Transcenta Holding does not currently pay a dividend.
Does Transcenta Holding pay a dividend?
Transcenta Holding does not currently pay a dividend.
When does Transcenta Holding next pay dividends?
Transcenta Holding does not currently pay a dividend.
How do I buy Transcenta Holding shares?
To buy shares in Transcenta Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Transcenta Holding?
As of the previous close price of HK$1.85, shares in Transcenta Holding had a market capitalisation of HK$807.29m.
Where are Transcenta Holding shares listed?
Here are the trading details for Transcenta Holding:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6628
What kind of share is Transcenta Holding?
Based on an overall assessment of its quality, value and momentum Transcenta Holding is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Transcenta Holding share price forecast for 2024?
The analyst consensus target price for shares in Transcenta Holding is HK$8.22. That is 344.09% above the last closing price of HK$1.85.
Analysts covering Transcenta Holding currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.76 for the next financial year.
What is the trend in the Transcenta Holding share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Transcenta Holding. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -49.86%.
As of the last closing price of HK$1.85, shares in Transcenta Holding were trading -41.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Transcenta Holding PE Ratio?
The Transcenta Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Transcenta Holding?
Transcenta Holding's management team is headed by:
- Yining Zhao - NEC
- Xueming Qian - CEO
- Weng Xiaolu - CFO
- Feng Ye - COO
- Christopher Hwang - EVP
- Xiaoming Yang - EVP
- Ming Shi - EVP
- Da Zhu - SVF
- Yi Gu - SVP
- Jane Qin Xia - VPR
- Kwan Wai Leung - SEC
- Jun Bao - NID
- Jiasong Tang - NID
- Zhihua Zhang - NID